Rubius Therapeutics has announced the pricing of its Nasdaq IPO, aiming to raise $200 million towards its novel cell therapies targeting cancer and autoimmune diseases. Based in Cambridge ...

100 Technology Way — 135,000 square feet on nine acres — is the former home of Rubius Therapeutics, a once-promising company ...

Rubius Therapeutics was unable to secure financing to carry out its pivot to a new manufacturing process for its red blood cell-based cell therapies. The once high-flying biotech is now exploring ...

"They are expanding their production facility to produce a line of artificial skin,” said Jeff Miller, EVP of investments and ...

The Rhode Island Commerce Corporation is scheduled to meet on Thursday morning to consider millions of dollars in incentives ...

Additionally, Rubius' Spanish viewers can get the emote for free by watching his Twitch stream for 1 hour. For Rubius, this ...

The content creation and social media sector has grown a lot in recent years and has reached levels that were difficult to ...

Popular Twitch streamer Rubius is about to get his own ICON skin in Fortnite. To celebrate, fans who tune in to the reveal ...

Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to ...

The Argentine topflight outfit is facing blowback after they included a social media influencer in their starting XI ...

Rubius Therapeutics is a biopharmaceutical company based in Cambridge, Massachusetts, USA, that is developing allogeneic cell therapies based on biologically engineered red blood cells (RBCs).

Rubius Therapeutics has announced the pricing of its Nasdaq IPO, aiming to raise $200 million towards its novel cell therapies targeting cancer and autoimmune diseases. Based in Cambridge ...